Clinical efficacy and safety evaluation of Buzhongyiqi pills on appetite improvement in patients with colorectal cancer receiving chemotherapy: a pilot randomized cross-over clinical trial.
BZYQP is feasible and safe to effectively improve the appetite of patients with CRC receiving chemotherapy and help them with better quality of life.
Authors
- Hongyi Hu (ORCID: https://orcid.org/0000-0003-3033-7467)
- Xiang Yan (ORCID: https://orcid.org/0000-0003-3544-9134)
- Aiguang Zhao
- Qian Jianan
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.20240806.005
- Citations
- 1
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Shanghai University of Traditional Chinese Medicine